Improve safety standards and oversight for human cell and tissue products.
One policy goal, tracked across every bill that has carried it.
What’s happening with Shandra Eisenga Human Cell and Tissue Product Safety Act?
The Shandra Eisenga Human Cell and Tissue Product Safety Act is represented by S. 4885, which was referred to the Senate Committee on Health, Education, Labor, and Pensions on June 23, 2026. The committee members must decide whether to hold a vote on the bill, but most bills fail because committees do not take action on them. This bill follows a similar proposal from February 4, 2024, that did not move forward before the legislative session ended.
Updated July 9, 2026 · Generated by AI. Always verify with official sources.
Where it stands
Now carried by Shandra Eisenga Human Cell and Tissue Product Safety Act (S. 4885 (119th)) →
Legislative Progress
How we got here
Every bill that has carried this goal, oldest first.
Died with Congress · Jan 3, 2025
Died when the 118th Congress ended without final passage. Bills must be reintroduced under a new number to be revived.
Reintroduced · Jan 3, 2025
Reintroduced from S. 3733 (118th), which died when its Congress ended.
S. 3733 (118th) →
Vehicles
Who’s behind it
Gary Peters (D-MI)Wrote and sponsored the current bill.